XiFin, Inc.

XiFin, Inc. is a healthcare information technology company headquartered in San Diego, California. The company's core business revolves around providing SaaS-based revenue cycle management (RCM) and workflow automation solutions. Its mission is to empower healthcare organizations to achieve financial strength, optimize operations, and navigate the complex healthcare landscape, ultimately enabling them to deliver better care to more patients.

XiFin offers a comprehensive suite of products and services, including the AI-enabled XiFin Empower RCM, clinical workflow enablement, laboratory information systems (LIS), medical billing outsourcing, and specialized solutions for pharmacy medical claim processing, clinical documentation, and patient communication (XiFin Fusion-Rx). The company serves a broad range of market segments, including clinical laboratories, molecular diagnostic providers, pathology practices, pain management clinics, toxicology labs, hospital outpatient and ancillary services, retail pharmacies, and medical device and telehealth organizations.

Under the leadership of Executive Chair and CEO Lâle White, XiFin has demonstrated significant growth and market positioning. The company reported strong operational growth in 2025, with its molecular diagnostics segment growing by 16.4% and its hospital segment by 13.3%, while volume through XiFin Empower RCM increased by 21.1%. XiFin was named to the Inc. 5000 list for the 13th time in August 2023, reflecting a 157% revenue growth over three years. In March 2026, XiFin announced its Empower AI RCM ecosystem, further advancing its AI strategy. The company supports a substantial portion of the healthcare market, including nearly 75% of the largest public laboratories, four out of five of the top integrated delivery networks, and over 30,000 retail pharmacies.